Skip to content

NeoGenomics NEO Reportable Segment — Other Nonoperating Income (Expense)

Similar metrics at other companies

Carvana logo
CVNAReportable Segment — Other Nonoperating Income (Expense)
-$41M-134%
Dollar Tree logo
DLTRReportable Segment — Other Nonoperating Income (Expense)
$5.4M-91.2%
Roivant Sciences logo
ROIVReportable Segment — Other Nonoperating Income (Expense)
$12.57M+542%
BOB
BOBSReportable segment — Other Nonoperating Income (Expense)
$0-100%
GRAIL, Inc. logo
GRALReportable Segment — Other Income (Expense)
$256K+144%
Marqeta logo
MQReportable Segment — Other income (expense)
$570K+2,092%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — other nonoperating income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — other nonoperating income (expense)?
NeoGenomics (NEO) reported reportable segment — other nonoperating income (expense) of -$12K in Q1 2026.
How has NeoGenomics's reportable segment — other nonoperating income (expense) changed year-over-year?
NeoGenomics's reportable segment — other nonoperating income (expense) decreased by 118.5% year-over-year, from $65K to -$12K.
What is the long-term trend for NeoGenomics's reportable segment — other nonoperating income (expense)?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — other nonoperating income (expense) has grown at a 11.6% compound annual growth rate (CAGR), from -$213K to $296K.
What does reportable segment — other nonoperating income (expense) mean?
This captures miscellaneous financial gains or losses that are not directly related to the core operational activities of the reportable segment. It includes items such as foreign exchange fluctuations, minor asset disposals, or other peripheral financial activities.